Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Thalassemia Intermedia,”

111 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 111 results

Testing effectiveness (Phase 2)Study completedNCT01186419
What this trial is testing

Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-thalassemia
Shire 51
Testing effectiveness (Phase 2)Study completedNCT00006136
What this trial is testing

Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

Who this might be right for
Beta-Thalassemia
Boston University 15
Testing effectiveness (Phase 2)Looking for participantsNCT03653338
What this trial is testing

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

Who this might be right for
Sickle Cell AnemiaBeta-thalassemia MajorDiamond-blackfan Anemia
Paul Szabolcs 5
Early research (Phase 1)WithdrawnNCT04176653
What this trial is testing

Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124

Who this might be right for
Non-transfusion-dependent ThalassemiaLow Risk Myelodysplastic Syndrome
Silence Therapeutics plc
Not applicableStudy completedNCT04526405
What this trial is testing

Frequency of COVID-19 Antibodies in Patients With Hereditary Hematological Diseases

Who this might be right for
Thalassemia MajorCovid19
University of Milano Bicocca 63
Testing effectiveness (Phase 2)Looking for participantsNCT04008368
What this trial is testing

Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels

Who this might be right for
Myeloid Chimerism
National Heart, Lung, and Blood Institute (NHLBI) 32
Testing effectiveness (Phase 2)Study completedNCT02049450
What this trial is testing

Study of Efficacy and Safety of INC424 in Regularly Transfused Patients With Thalassemia.

Who this might be right for
Thalassemia Major
Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)Ended earlyNCT01363908
What this trial is testing

Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron Overload

Who this might be right for
Transfusional Iron OverloadBeta-Thalassemia
Shire 30
Early research (Phase 1)Ended earlyNCT02274233
What this trial is testing

Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-Thalassemia

Who this might be right for
Iron OverloadBeta-Thalassemia
Sideris Pharmaceuticals 24
Testing effectiveness (Phase 2)Ended earlyNCT00115349
What this trial is testing

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Who this might be right for
Cardiovascular DiseasesHeart DiseasesBeta-Thalassemia
Carelon Research 20
Not applicableLooking for participantsNCT05773729
What this trial is testing

Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent Beta-thalassemia

Who this might be right for
β-thalassemia
Shanghai BDgene Co., Ltd. 10
Early research (Phase 1)Study completedNCT00005783
What this trial is testing

A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

Who this might be right for
Hemoglobin SC DiseaseSickle Cell Anemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Large-scale testing (Phase 3)Study completedNCT00171171
What this trial is testing

Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional Hemosiderosis

Who this might be right for
Beta-ThalassemiaHemosiderosis
Novartis 252
Large-scale testing (Phase 3)UnknownNCT01511848
What this trial is testing

Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload

Who this might be right for
Beta-thalassemia MajorSickle Cell DiseaseIron Hemosiderosis
Ain Shams University 60
Not applicableNot Yet RecruitingNCT07288762
What this trial is testing

Gonadal Function in Thalassemic Patient

Who this might be right for
Thalassemia Majors (Beta-Thalassemia Major)
Sohag University 80
Testing effectiveness (Phase 2)Study completedNCT02559648
What this trial is testing

Denosumab vs Placebo in Patients With Thalassemia Major and Osteoporosis

Who this might be right for
Thalassemia MajorOsteoporosis
Ersi Voskaridou 63
Not applicableLooking for participantsNCT06073860
What this trial is testing

A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia

Who this might be right for
Myelodysplastic SyndromeBeta Thalassemia
Bristol-Myers Squibb 104
Not applicableActive Not RecruitingNCT04691323
What this trial is testing

The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.

Who this might be right for
Sickle Cell DiseaseSickle B+ ThalassemiaSickle Beta Zero Thalassemia+1 more
Ann & Robert H Lurie Children's Hospital of Chicago 68
Not applicableStudy completedNCT04367701
What this trial is testing

Congenital Heart Surgery in Pediatric Patients With Beta-Thalassemia Major

Who this might be right for
Hemolysis
Ain Shams University 41
Not applicableStudy completedNCT00005893
What this trial is testing

Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders

Who this might be right for
NeutropeniaSickle Cell AnemiaThalassemia Major+1 more
Fairview University Medical Center
Load More Results